Q1 2025 Earnings Call Transcript April 17, 2025 Marsh & McLennan Companies, Inc. beats earnings expectations. Reported EPS is ...

John Doyle; President, Chief Executive Officer, Director; Marsh & McLennan Companies Inc Mark McGivney; Chief Financial Officer; Marsh & McLennan Companies Inc Martin South; President, Chief Executive ...

These agreements aim to enhance real estate services, promote transparency, support women in the sector, and drive the adoption of smart solutions and technological innovation ...

A public university in Las Vegas, New Mexico is suing the Federal Emergency Management Agency, alleging the agency is illegally forcing it to jump through bureaucratic hoops before it can seek ...

The Jabalpur bench of the Madhya Pradesh High Court while answering a reference made by a single judge, clarified that an ...

This would allow for the reduction or elimination of the water treatment step, which is a long-term cost and liability ...

Liberty and justice are under attack as the Trump regime’s assault on due process and unlawful deportations escalates. It’s ...

Alex Miller’s protocol goes beyond the “squeeze and hold” method. It includes dynamic movement patterns that integrate ...

We are presenting at the Santangel’s Roundtable in New York City on Wednesday 7th May 2025 and look forward to meeting to ...

MetroCity Bankshares, Inc. ("MetroCity" or the "Company") , holding company for Metro City Bank (the "Bank"), today reported net income of $16.3 million, or $0.63 per diluted share, for the first ...

• For 3 months ended March 31, 2025, the Company's net interest margin increased to 2.68% compared to 2.50% for the 3 months ended December 31, 2024. • The Company sold $3 million in SBA 7a loan ...

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...